Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.41% | 171.81 | 0.0% | $763.68m | |
| AMGN | Amgen, Inc. | -1.48% | 248.35 | 1.5% | $601.54m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.22% | 292.16 | 1.9% | $427.81m | |
| GILD | Gilead Sciences, Inc. | -1.09% | 62.45 | 1.0% | $396.17m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.74% | 623.90 | 2.6% | $359.24m | |
| NVAX | Novavax, Inc. | -2.47% | 40.34 | 75.7% | $337.27m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 9.21% | 4.03 | 0.7% | $281.71m | |
| ILMN | Illumina, Inc. | 0.06% | 227.44 | 3.3% | $245.24m | |
| BIIB | Biogen, Inc. | -1.28% | 218.22 | 1.8% | $201.29m | |
| BNTX | BioNTech SE | -1.45% | 158.59 | 0.0% | $159.39m | |
| GOVX | GeoVax Labs, Inc. | -1.10% | 2.70 | 0.0% | $138.58m | |
| CRSP | CRISPR Therapeutics AG | -1.79% | 77.46 | 0.6% | $118.69m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.97% | 95.07 | 4.2% | $100.00m | |
| RYTM | Rhythm Pharmaceuticals, Inc. | -7.26% | 19.94 | 0.0% | $93.96m | |
| MRTX | Mirati Therapeutics, Inc. | -3.13% | 80.45 | 1.6% | $91.58m |
Company Profile
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.